Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive

Bence Kovári, Orsolya Rusz, Andrew V Schally, Zsuzsanna Kahán, Gábor Cserni

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Different classes of breast cancers were explored for their positivity for growth hormone-releasing hormone receptors (GHRH-R) in this pilot study, as no systematic evaluation of such tumors has been performed to date. Seventy-two small primary breast carcinomas were evaluated for GHRH-R expression by immunohistochemistry using a polyclonal antibody and a cutoff value of 10% staining. GHRH-R positivity was detected in 58% of all cases, 20/23 (87%) of invasive lobular carcinomas (ILC) and 22/46 (48%) of invasive ductal carcinomas (IDC). GHRH-R positivity was more frequent in grade 2 tumors (86%), as compared to grade 1 (18%) or grade 3 (47%) cancers. GHRH-R expression was not associated with mitotic scores, the Ki-67 labeling indices or nodal status. IDCs with casting-type calcifications on the mammogram showed positivity for GHRH-R in 9/12 (75%) cases. Most importantly, apocrine epithelium, and all 10 apocrine carcinomas added later to the study were GHRH-R-positive. These preliminary results suggest a greater than average GHRH-R expression in ILCs and IDCs associated with casting-type calcifications on the mammogram. Apocrine carcinomas seem uniformly positive for GHRH-R. Whether these findings could indicate a potential role of GHRH-antagonists in targeted treatment of these types of breast cancer requires further studies.

Original languageEnglish
Pages (from-to)824-831
Number of pages8
JournalAPMIS
Volume122
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Epithelium
Breast Neoplasms
Carcinoma
Lobular Carcinoma
Neoplasms
Ductal Carcinoma
somatotropin releasing hormone receptor
Immunohistochemistry
Staining and Labeling
Antibodies

Keywords

  • Apocrine carcinoma
  • Breast cancer
  • Growth hormone-releasing hormone receptor
  • Immunohistochemistry

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Microbiology (medical)
  • Immunology and Allergy
  • Medicine(all)

Cite this

Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive. / Kovári, Bence; Rusz, Orsolya; Schally, Andrew V; Kahán, Zsuzsanna; Cserni, Gábor.

In: APMIS, Vol. 122, No. 9, 01.01.2014, p. 824-831.

Research output: Contribution to journalArticle

@article{d6c40a264d5a47908fc6bf921914b984,
title = "Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive",
abstract = "Different classes of breast cancers were explored for their positivity for growth hormone-releasing hormone receptors (GHRH-R) in this pilot study, as no systematic evaluation of such tumors has been performed to date. Seventy-two small primary breast carcinomas were evaluated for GHRH-R expression by immunohistochemistry using a polyclonal antibody and a cutoff value of 10{\%} staining. GHRH-R positivity was detected in 58{\%} of all cases, 20/23 (87{\%}) of invasive lobular carcinomas (ILC) and 22/46 (48{\%}) of invasive ductal carcinomas (IDC). GHRH-R positivity was more frequent in grade 2 tumors (86{\%}), as compared to grade 1 (18{\%}) or grade 3 (47{\%}) cancers. GHRH-R expression was not associated with mitotic scores, the Ki-67 labeling indices or nodal status. IDCs with casting-type calcifications on the mammogram showed positivity for GHRH-R in 9/12 (75{\%}) cases. Most importantly, apocrine epithelium, and all 10 apocrine carcinomas added later to the study were GHRH-R-positive. These preliminary results suggest a greater than average GHRH-R expression in ILCs and IDCs associated with casting-type calcifications on the mammogram. Apocrine carcinomas seem uniformly positive for GHRH-R. Whether these findings could indicate a potential role of GHRH-antagonists in targeted treatment of these types of breast cancer requires further studies.",
keywords = "Apocrine carcinoma, Breast cancer, Growth hormone-releasing hormone receptor, Immunohistochemistry",
author = "Bence Kov{\'a}ri and Orsolya Rusz and Schally, {Andrew V} and Zsuzsanna Kah{\'a}n and G{\'a}bor Cserni",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/apm.12224",
language = "English",
volume = "122",
pages = "824--831",
journal = "Acta pathologica et microbiologica Scandinavica",
issn = "0365-5555",
publisher = "Munksgaard International Publishers",
number = "9",

}

TY - JOUR

T1 - Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive

AU - Kovári, Bence

AU - Rusz, Orsolya

AU - Schally, Andrew V

AU - Kahán, Zsuzsanna

AU - Cserni, Gábor

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Different classes of breast cancers were explored for their positivity for growth hormone-releasing hormone receptors (GHRH-R) in this pilot study, as no systematic evaluation of such tumors has been performed to date. Seventy-two small primary breast carcinomas were evaluated for GHRH-R expression by immunohistochemistry using a polyclonal antibody and a cutoff value of 10% staining. GHRH-R positivity was detected in 58% of all cases, 20/23 (87%) of invasive lobular carcinomas (ILC) and 22/46 (48%) of invasive ductal carcinomas (IDC). GHRH-R positivity was more frequent in grade 2 tumors (86%), as compared to grade 1 (18%) or grade 3 (47%) cancers. GHRH-R expression was not associated with mitotic scores, the Ki-67 labeling indices or nodal status. IDCs with casting-type calcifications on the mammogram showed positivity for GHRH-R in 9/12 (75%) cases. Most importantly, apocrine epithelium, and all 10 apocrine carcinomas added later to the study were GHRH-R-positive. These preliminary results suggest a greater than average GHRH-R expression in ILCs and IDCs associated with casting-type calcifications on the mammogram. Apocrine carcinomas seem uniformly positive for GHRH-R. Whether these findings could indicate a potential role of GHRH-antagonists in targeted treatment of these types of breast cancer requires further studies.

AB - Different classes of breast cancers were explored for their positivity for growth hormone-releasing hormone receptors (GHRH-R) in this pilot study, as no systematic evaluation of such tumors has been performed to date. Seventy-two small primary breast carcinomas were evaluated for GHRH-R expression by immunohistochemistry using a polyclonal antibody and a cutoff value of 10% staining. GHRH-R positivity was detected in 58% of all cases, 20/23 (87%) of invasive lobular carcinomas (ILC) and 22/46 (48%) of invasive ductal carcinomas (IDC). GHRH-R positivity was more frequent in grade 2 tumors (86%), as compared to grade 1 (18%) or grade 3 (47%) cancers. GHRH-R expression was not associated with mitotic scores, the Ki-67 labeling indices or nodal status. IDCs with casting-type calcifications on the mammogram showed positivity for GHRH-R in 9/12 (75%) cases. Most importantly, apocrine epithelium, and all 10 apocrine carcinomas added later to the study were GHRH-R-positive. These preliminary results suggest a greater than average GHRH-R expression in ILCs and IDCs associated with casting-type calcifications on the mammogram. Apocrine carcinomas seem uniformly positive for GHRH-R. Whether these findings could indicate a potential role of GHRH-antagonists in targeted treatment of these types of breast cancer requires further studies.

KW - Apocrine carcinoma

KW - Breast cancer

KW - Growth hormone-releasing hormone receptor

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=84906791981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906791981&partnerID=8YFLogxK

U2 - 10.1111/apm.12224

DO - 10.1111/apm.12224

M3 - Article

C2 - 24479854

AN - SCOPUS:84906791981

VL - 122

SP - 824

EP - 831

JO - Acta pathologica et microbiologica Scandinavica

JF - Acta pathologica et microbiologica Scandinavica

SN - 0365-5555

IS - 9

ER -